GlassScriptPhysician profile
Reba Beard
NPI 1982665956
$959.88
in general payments reported to CMS, 2019-2025
18 companies · $53.88 in 2025
The $53.88 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $95.53 · 2021: $180 · 2022: $192 · 2023: $223 · 2024: $113 · 2025: $53.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $221.77 | 2021-2023 | Azstarys |
| Sobi, INC | $132.17 | 2019-2022 | |
| Kyowa Kirin, INC. | $71.78 | 2024-2025 | Crysvita |
| Ironshore Pharmaceuticals INC. | $69.83 | 2019-2023 | Jornay Pm |
| Adlon Therapeutics L.P. | $62.03 | 2019-2021 | |
| Pfizer INC. | $51.47 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $49.96 | 2023-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Tris Pharma INC | $49.88 | 2021-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $45.31 | 2022-2023 | |
| Ultragenyx Pharmaceutical INC. | $40.22 | 2021-2023 | |
| Kaleo, INC. | $38.10 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $26.79 | 2025 | Neffy |
| Mission Pharmacal Company | $19.75 | 2019 | |
| Seqirus USA INC | $18.43 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.72 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $17.28 | 2024 | Adzenys Xr-Odt |
| Glaxosmithkline, LLC. | $14.66 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reba Beard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.